Yael Schejter-Dinur
Jerusalem, JM, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
CARMIL2 deficiency disrupts activation-induced metabolic reprogramming in T cells and is partially rescued by glutamine supplementation.
Journal: The Journal of allergy and clinical immunology
Published: February 20, 2025
Risk and promise: an 11-year, single-center retrospective study of severe acute GVHD in pediatric patients undergoing allogeneic HSCT for nonmalignant diseases.
Journal: Frontiers in pediatrics
Published: March 27, 2023
Management of Atopy with Dupilumab and Omalizumab in CADINS Disease.
Journal: Journal of clinical immunology
Published: March 22, 2023
Neurological complications following pediatric allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.
Journal: Frontiers in pediatrics
Published: October 07, 2022
Vedolizumab for pediatric patients with gastrointestinal acute graft-versus-host-disease.
Journal: Pediatric blood & cancer
Published: July 11, 2022
Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.
Journal: The Journal of experimental medicine
Published: February 15, 2022
Social determinants of health and primary immunodeficiency.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: July 11, 2021
The Clinical Aspect of Adaptor Molecules in T Cell Signaling: Lessons Learnt From Inborn Errors of Immunity.
Journal: Frontiers in immunology
Published: April 28, 2021
Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel.
Journal: Frontiers in immunology
Published: October 05, 2020
Bacillus Calmette-Guerin (BCG) Vaccine-associated Complications in Immunodeficient Patients Following Stem Cell Transplantation.
Journal: Journal of clinical immunology
Published: June 25, 2020
Haploidentical stem cell transplantation with post-transplant cyclophosphamide for osteopetrosis and other nonmalignant diseases.
Journal: Bone marrow transplantation
Published: May 02, 2020
Last Updated: 09/26/2026